NeuronAlgo
~/backtests/na-nas-l-003 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Rasalhague

code: NA-NAS-L-003 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $7,996 trades 305 win 51.64%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $7,996
gross profit$29,315
gross loss$21,319
win_rate
51.64%WIN
█████░░░░░
Win rate
157W / 147L
profit_factor
1.38PF
█████░░░░░
Profit factor
gross P / gross L
cagr
2.98%CAGR
░░░░░░░░░
CAGR
annualized
max_drawdown
-16.06%MAX DD
██░░░░░░░░
Max drawdown
$1,623
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 610 points; starts at $10,000.00, ends at $17,995.80; observed range $8,481.98–$18,295.40.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
51.64%win
Wins157
Losses147
Total305
win_vs_loss_size
Avg win$186.72
Avg loss$145.03
Largest win$717.62
Largest loss-$214.32
key_ratios
Profit factor1.38
Win/Loss ratio1.07
Payout ratio1.29
Expectancy$26.22
Avg trade$26.22
Bars in trade24.28
streaks
Max consec wins8
Max consec losses8
Avg consec wins1.00
Avg consec losses1.00
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$7,996
Net profit
$29,315
Gross profit
$21,319
Gross loss
2.98%
CAGR
3.81
AHPR
$400
Yearly avg profit
$33
Monthly avg profit
$1.07
Daily avg profit
4.00%
Yearly avg return
7.47%
Exposure
305
Trades
$26.22
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips104234.99 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top